H.R. 6436 · 118th Congress (2023–2025)
Stopping Pharma’s Ripoffs and Drug Savings For All Act
To amend title 35, United States Code, to prevent double patenting, and for other purposes.
CRS summary not yet available.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is H.R. 6436’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Patrick Ryan (D-NY-18)
- Policy area
- Commerce
- Subjects
- Advisory bodies
- Business records
- Electric power generation and transmission
- Emergency planning and evacuation
- Employment and training programs
- Government studies and investigations
- Industrial facilities
- Infectious and parasitic diseases
2 more
- Nuclear power
- Radioactive wastes and releases
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on the Judiciary.
Sources
- Congress.gov action
- House floor actions
Expired
Introduced → Referred to House Judiciary → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Stopping Pharma’s Ripoffs and Drug Savings For All Act
Display title, Short title · Introduced in House
To amend title 35, United States Code, to prevent double patenting, and for other purposes.
Official title · Introduced in House